The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 15, 2022
Filed:
Oct. 09, 2019
Applicant:
Immunsys, Inc., Fort Lauderdale, FL (US);
Inventors:
Gary Onik, Fort Lauderdale, FL (US);
James A. Miessau, Branford, CT (US);
Assignee:
ImmunSYS, Inc., Fort Lauderdale, FL (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 18/02 (2006.01); A61N 1/32 (2006.01); A61P 35/00 (2006.01); A61K 38/19 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61B 18/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61B 18/14 (2013.01); A61B 18/02 (2013.01); A61K 38/193 (2013.01); A61K 39/39558 (2013.01); A61N 1/327 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); C07K 16/2863 (2013.01); C07K 16/2878 (2013.01); C07K 16/2896 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00994 (2013.01); A61B 2018/0293 (2013.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01);
Abstract
Provided herein are new compositions, methods, and devices to treat cancer through a combination of immunologic chemotherapeutic agents and ablation techniques. These compositions can include immune checkpoint inhibitors, cytokines and nucleic acid drugs that aid in eliciting an immune response to treat the tumor. The administration of these compositions in addition to various ablating techniques provides a presentation of the cancer cell antigens to the immune system and the immunologic targeting of the cancer.